Early treatment study
et al., medRxiv doi:10.1101/2020.04.20.20072421.t (Preprint)
COVID-19 in Iran, a comprehensive investigation from exposure to treatment outcomes
Small limited trial with 100 patients concluding that HC
Q improved clinical outcome, OR 0.016 [0.002-0.11] in regression analysis.
death, ↓67.5%, p=0.15
Please send us corrections, updates, or comments.